DALLAS--(BUSINESS WIRE)--Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases, today announced full year 2022 results and provided a ...
Here’s the Kia Forte, the brand’s oft-forgotten compact sedan. After a slate of updates applied for 2022, can the Forte renew its competitive position against newer—and legitimately excellent—small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results